These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 17596725

  • 1. Elimination of lipid peroxide during hemodialysis.
    Obara M, Hirayama A, Gotoh M, Ueda A, Ishizu T, Taru Y, Shimozawa Y, Yamagata K, Nagase S, Koyama A.
    Nephron Clin Pract; 2007; 106(4):c162-8. PubMed ID: 17596725
    [Abstract] [Full Text] [Related]

  • 2. Effect of long-term hemodialysis on plasma lecithin: cholesterol acyltransferase activity and the amounts and compositions of HDL2 and HDL3 in hemodialysis-treated patients with chronic renal failure: a 9-year longitudinal study.
    Mekki K, Bouchenak M, Remaoun M, Belleville JL.
    Med Sci Monit; 2004 Aug; 10(8):CR439-46. PubMed ID: 15277993
    [Abstract] [Full Text] [Related]

  • 3. Fate of lipid hydroperoxides in blood plasma.
    Yamamoto Y.
    Free Radic Res; 2000 Dec; 33(6):795-800. PubMed ID: 11237101
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Plasma glutathione peroxidase reduces phosphatidylcholine hydroperoxide.
    Yamamoto Y, Nagata Y, Niki E, Watanabe K, Yoshimura S.
    Biochem Biophys Res Commun; 1993 May 28; 193(1):133-8. PubMed ID: 8503899
    [Abstract] [Full Text] [Related]

  • 7. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron.
    Prakash M, Upadhya S, Prabhu R.
    Clin Chim Acta; 2005 Oct 28; 360(1-2):194-8. PubMed ID: 15979061
    [Abstract] [Full Text] [Related]

  • 8. Oxidative stress in hemodialysis--postdialytic changes.
    Dakshinamurty KV, Rao PV, Saibaba KS, Sheela RB, Sreekrishna V, Venakataramana G, Shyam C, Jayaseelan L.
    Clin Lab; 2003 Oct 28; 49(5-6):255-61. PubMed ID: 15285183
    [Abstract] [Full Text] [Related]

  • 9. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J, Santos F, Grosso D, Lima R, Barreira AL, Leite M, Mafra D, Abdalla DS.
    Nephron Clin Pract; 2008 Oct 28; 108(4):c298-304. PubMed ID: 18434752
    [Abstract] [Full Text] [Related]

  • 10. Elevated hepatocyte growth factor levels at the beginning of high-flux hemodialysis are due to heparin administration.
    Christidou F, Bamichas G, Galaktidou G, Fragidis S, Gionanlis L, Frangia T, Bischiniotis T, Sombolos K.
    Ren Fail; 2008 Oct 28; 30(9):861-4. PubMed ID: 18925524
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Body mass index and cardiovascular risk factors and biomarkers in hemodialysis patients.
    Bossola M, Giungi S, Panocchia N, Vulpio C, Luciani G, Tazza L.
    J Nephrol; 2008 Oct 28; 21(2):197-204. PubMed ID: 18446714
    [Abstract] [Full Text] [Related]

  • 13. An improved HPLC assay for phosphatidylcholine hydroperoxides (PCOOH) in human plasma with synthetic PCOOH as internal standard.
    Hui SP, Chiba H, Sakurai T, Asakawa C, Nagasaka H, Murai T, Ide H, Kurosawa T.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep 15; 857(1):158-63. PubMed ID: 17627906
    [Abstract] [Full Text] [Related]

  • 14. Oral vitamin C supplementation in hemodialysis patients and its effect on the plasma level of oxidized ascorbic acid and Cu/Zn superoxide dismutase, an oxidative stress marker.
    Washio K, Inagaki M, Tsuji M, Morio Y, Akiyama S, Gotoh H, Gotoh T, Gotoh Y, Oguchi K.
    Nephron Clin Pract; 2008 Sep 15; 109(2):c49-54. PubMed ID: 18544955
    [Abstract] [Full Text] [Related]

  • 15. Physical activity, high-density lipoprotein cholesterol subfractions and lecithin:cholesterol acyltransferase in dialysis patients.
    Masuda R, Imamura H, Mizuuchi K, Miyahara K, Kumagai H, Hirakata H.
    Nephron Clin Pract; 2009 Sep 15; 111(4):c253-9. PubMed ID: 19293594
    [Abstract] [Full Text] [Related]

  • 16. [Products of lipid peroxidation in the blood plasma of patients with chronic renal insufficiency treated with hemodialysis].
    Nikiforova NV, Sokolovskaia IV.
    Ter Arkh; 1980 Sep 15; 52(4):55-7. PubMed ID: 7404338
    [No Abstract] [Full Text] [Related]

  • 17. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H, Nakayama K, Matsuyama Y, Nakayama M, Sato T, Hosoya T, Era S, Ito S.
    Blood Purif; 2007 Sep 15; 25(3):274-9. PubMed ID: 17460395
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Coenzyme Q10 administration suppresses both oxidative and antioxidative markers in hemodialysis patients.
    Sakata T, Furuya R, Shimazu T, Odamaki M, Ohkawa S, Kumagai H.
    Blood Purif; 2008 Sep 15; 26(4):371-8. PubMed ID: 18509244
    [Abstract] [Full Text] [Related]

  • 20. Spontaneous DNA repair increases during hemodialysis.
    Herman M, Ori Y, Chagnac A, Korzets A, Weinstein T, Malachi T, Gafter U.
    Nephron Clin Pract; 2008 Sep 15; 108(3):c188-93. PubMed ID: 18311083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.